Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for the quarter ending 2026-06-30 was $39.5B, a 105.71% increase year-over-year.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for the quarter ending 2026-03-31 was $35.06B, a 98.88% increase year-over-year.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for the quarter ending 2025-12-31 was $35.89B, a 43.60% increase year-over-year.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for the quarter ending 2025-09-30 was $23.21B, a 13.67% increase year-over-year.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for fiscal 2026 was $39.5B.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for fiscal 2025 was $35.89B, a 43.60% increase from fiscal 2024.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for fiscal 2024 was $24.99B, a 113.51% increase from fiscal 2023.
TEVA PHARMACEUTICAL INDUSTRIES LTD market cap for fiscal 2023 was $11.7B, a 15.52% increase from fiscal 2022.